Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar mblin13 (38.06) Submitted: 3/1/2007 1:44:09 PM : Outperform Start Price: $19.32 REGN Score: +584.29

possible double

Featured Broker Partners


Advertisement